Search Results

1 - 10 of 117
Fact Sheet
En la actualidad, la terapia génica para la enfermedad de células falciformes se considera experimental y solo está a su disposición si participa en un estudio clínico.
Fact Sheet
Actualmente, existen diferentes enfoques de terapia génica disponibles a través de ensayos clínicos.
Fact Sheet
Diversos enfoques se dirigen a las células madre sanguíneas para aliviar o reducir los síntomas de la anemia de células falciformes.
Fact Sheet
Comprender la terapia génica para la enfermedad de células falciformes
Health FAQ
Comente estas preguntas con su médico o su equipo del estudio clínico.
Hoja Informativa
Su salud mental y su salud física están íntimamente conectadas. La salud mental es importante para su salud y su calidad de vida.
AnVIL
The Data Use Oversight System (DUOS) is a semi-automated study registration and DAR management service informed by the GA4GH DUO standard, which enables the secondary use of human genomics and other controlled-access data in compliance with the informed consent of a study’s participants.
Event
On May 19-20, 2016, the National Human Genome Research Institute (NHGRI) hosted a two-day workshop where participants were asked to weigh the benefits and risks of sharing aggregate genomic data with secondary users.
Event
On April 16-17, 2018, the National Human Genome Research Institute (NHGRI) and the Eunice Kennedy Shriver National Institute of CHild Health and Human Development (NICHD) hosted a joint workshop - Genomic Medicine for Reproductive, Prenatal and Neonatal Health.
Event
As the National Institutes of Health’s Newborn Sequencing in Genomic Medicine and Public Health (NSIGHT) program comes to a close, the NSIGHT program holds a public webinar on June 24, 2019, during its final steering committee meeting.